Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

John Robert Hutchison has worked on the following 7 EPO patent applications which have been published in the last five years:

EP12711872

ALISPORIVIR TO TREAT HEPATITIS C VIRUS INFECTION

IPC classification:
A61K 31/395, A61P 31/14
Applicant:
Novartis AG
Agent:
John Robert Hutchison, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12700262

IMMUNOSUPPRESSANT FORMULATIONS

IPC classification:
A61K 9/20, A61K 31/397
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Ter Meer Steinmeister & Partner PartGmbB
Status:
EXAMINATION IN PROGRESS
EP11719705

PREDICTIVE MARKERS USEFUL IN THE TREATMENT OF FRAGILE X SYNDROME (FXS)

IPC classification:
C12Q 1/68
Applicant:
Novartis AG
Agent:
John Robert Hutchison, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10803319

Formulation comprising1 h-quinazoline-2,4-dione ampa receptor antagonists. in the form of immediate release tablets and preparation thereof

IPC classification:
A61K 9/14, A61K 9/16, A61K 9/20, A61K 31/517, A61P 25/08, A61P 25/16, A61P 25/18, A61P 25/24, A61P 25/28
Applicant:
Novartis AG
Agent:
John Robert Hutchison, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11727192

USE OF 1H-QUINAZOLINE-2,4-DIONES

IPC classification:
A61K 31/517, A61P 25/00
Applicant:
Novartis AG
Agent:
John Robert Hutchison, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP16169370

TREATMENT WITH VILDAGLIPTIN

IPC classification:
A61K 9/16, A61K 9/20
Applicant:
Novartis AG
Applicant:
Novartis Pharma GmbH
Agent:
John Robert Hutchison, Novartis AG
Status:
Request for examination was made
EP11183758

IMMUNOSUPPRESSANT COMPOUNDS AND COMPOSITIONS

IPC classification:
A61K 31/135, A61P 29/00, C07C 251/48, C07C 251/52, C07C 251/54, C07D 205/04, C07D 207/16, C07D 211/60, C07D 213/30, C07D 213/53, C07D 213/61, C07D 217/04, C07D 295/06, C07D 307/10, C07D 307/12, C07D 307/52, C07D 333/12, C07D 333/16, C07D 333/22
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Ter Meer Steinmeister & Partner PartGmbB
Status:
PATENT GRANTED

Please Sign in to use this feature